Cargando…

Evidence-Based Guidelines Should Be Used To Inform COVID-19 Management

Detalles Bibliográficos
Autor principal:	Holland, Thomas L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092555/ https://www.ncbi.nlm.nih.gov/pubmed/33288635 http://dx.doi.org/10.1128/AAC.02501-20

Ejemplares similares

Should statins be considered for the management of mucormycosis in COVID-19?
por: Chatterjee, Subhankar, et al.
Publicado: (2021)

Time-Sensitive Therapeutic Interventions at Diagnosis of Sepsis: Should Guidelines Be Confined to High-Level Evidence?
por: Oud, Lavi
Publicado: (2019)

Should We Use DSI or not—What does the PADIS 2018 Guidelines Recommend?
por: Sharma, Ankur, et al.
Publicado: (2019)

Comments on: Preferred practice guidelines for glaucoma management during COVID-19 pandemic
por: Parikh, Rajul S, et al.
Publicado: (2020)

Ketoacidosis in type 1 diabetics: we should return to pediatric guidelines
por: Redant, Sébastien, et al.
Publicado: (2020)

Nevertheless, the importance of coagulation abnormalities should be emphasized in international sepsis guidelines
por: Iba, Toshiaki, et al.
Publicado: (2022)

Response to “Should estrogen be used in the co-treatment of COVID-19 patients?”
por: Cano, Antonio, et al.
Publicado: (2020)

CPR in COVID-19: Should We Use the PAPR to Keep the Savior Safe?
por: Saran, Sai
Publicado: (2021)

Should estrogen be used in the co-treatment of COVID-19 patients? What is the rationale?
por: Hamzaoglu, Kubra, et al.
Publicado: (2020)

Why the article that led to the widespread use of hydroxychloroquine in COVID-19 should be retracted
por: Barraud, Damien, et al.
Publicado: (2023)

Healthcare students: should they be prioritized for COVID-19 vaccination?
por: Riva, Michele Augusto, et al.
Publicado: (2021)

COVID-19 should be a methylene blue “promoter”
por: Evora, Paulo Roberto B.
Publicado: (2020)

Guidelines Are Urgently Needed for the Use of Preprints as a Source of Information
por: Ide, Kazuki, et al.
Publicado: (2021)

The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries
por: Adebisi, Yusuff Adebayo, et al.
Publicado: (2021)

Countries should localize the guidelines of the World Health Organization to be effective according to their country's conditions
por: MOHAMMADI, MASOUD
Publicado: (2023)

Regional differences in use of immune-modulating catechins should be investigated regarding COVID-19
por: Catherine DeSoto, M.
Publicado: (2020)

Response to comments on: Preferred practice guidelines for glaucoma management during COVID-19 pandemic
por: Tejwani, Sushma, et al.
Publicado: (2020)

ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply
por: Bartoletti, Michele, et al.
Publicado: (2022)

COVID-19: What approach should people take to prevent it?
por: Saghafipour, Abedin, et al.
Publicado: (2021)

COVID-19, steroids, and mucormycosis: What an ophthalmologist should know
por: Tandon, Abhishek, et al.
Publicado: (2021)

Should all COVID-19 patients be approached in the same way?
por: Fernandes, Caio Julio Cesar dos Santos
Publicado: (2020)

Hemoptysis in COVID-19: Pulmonary Emboli Should be Ruled Out
por: Ozaras, Resat, et al.
Publicado: (2020)

COVID-19 & antiepileptic drugs: Should we pay attention?
por: Fırat, Oguzhan, et al.
Publicado: (2020)

COVID-19 should not be taken lightly — Mitigation at the end of the lockdown
por: Pal, Shrayan
Publicado: (2020)

COVID-19 and Kawasaki syndrome: should we really be surprised?
por: Loomba, Rohit S., et al.
Publicado: (2020)

Ramadan Coincides With the COVID-19 Pandemic: What Should Be Done?
por: Hosseini Zijoud, Seyed Reza, et al.
Publicado: (2020)

Randomized Controlled Trials on COVID-19 Should Be Accurate and Trustworthy
por: Mol, Ben W.
Publicado: (2022)

Should COVID-19 be considered cardiovascular disease risk equivalent?
por: Kow, Chia Siang, et al.
Publicado: (2023)

COVID-19: Decisions to Offer Interventions With Limited Availability Should Be Decided Based on Chance of Recovery
por: Gallina, Pasquale, et al.
Publicado: (2020)

Factor VIII, Fibrinogen and Heparin Resistance in COVID-19 Patients with Thromboembolism: How Should We Manage the Anticoagulation Therapy?
por: Savioli, Felicio, et al.
Publicado: (2022)

Should beach travel in the Philippines resume during the COVID-19 outbreak?
por: Opiniano, G.A., et al.
Publicado: (2021)

COVID-19 second wave: lockdown should not mean lock-up
por: Vedhara, K.
Publicado: (2021)

Declaration of conflict of interest for reviewers in time of COVID-19 should be mandatory
por: Chirico, Francesco, et al.
Publicado: (2021)

Should people with chronic liver diseases be vaccinated against COVID-19?
por: Chen, Li-Ping, et al.
Publicado: (2021)

Getting Access to the COVID-19 Vaccine: What Should Be Our Approach?
por: Kumar, Subodh, et al.
Publicado: (2021)

COVID-19 outbreak: What should be done to avoid food shortages?
por: de Paulo Farias, David, et al.
Publicado: (2020)

COVID-19: should oral vaccination strategies be given more consideration?
por: Mehan, Aman, et al.
Publicado: (2020)

Reflections and recommendations on the COVID-19 pandemic: Should hormone therapy be discontinued?
por: Cagnacci, A., et al.
Publicado: (2020)

Prescribing COVID-19 treatments: what we should never forget
por: Tunesi, S., et al.
Publicado: (2020)

Research on Drugs and Vaccines for COVID-19 Should Be Conducted and Published With Caution
por: Chen, Fei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5neds1u1gmctigm8eu8mqrr9h9